Cambridge Investment Research Advisors
PARN

Cambridge Investment Research Advisors’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,999
Closed -$14K – 1857
2016
Q4 		$14K Buy
19,999
+9,999
+100% +$11.9K ﹤0.01% 1658
2016
Q3 		$14K Hold
10,000
– – ﹤0.01% 1733
2016
Q2 		$16K Buy
+10,000
New +$18.4K ﹤0.01% 1542

Other funds holding PARN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Cambridge Investment Research Advisors's PARN Position: Q1 2017 in Review

Cambridge Investment Research Advisors sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2017, closing a stake of 19,999 shares — an estimated $14K sold.

Cambridge Investment Research Advisors first reported a position in PARN in Q2 2016 and held it in 3 quarters. The position peaked at $16K in Q2 2016. 2 funds tracked by Wall St. Rank hold PARN as of Q1 2017.

  • Cambridge Investment Research Advisors reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2017 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 19,999 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2017, an estimated $14K.
  • Cambridge Investment Research Advisors first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q2 2016 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's Parnell Pharmaceuticals Holdings Ltd position peaked at $16K in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2017.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2017, filed 12 May 2017.